Article info
Clinical and epidemiological research
Extended report
Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?
- Correspondence to Dr Dafna Gladman, Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto Psoriatic Arthritis Clinic, Suite No 1E-410B, Toronto Western Hospital, 399 Bathurst Street, Toronto, Ontario, Canada M5T 2S8; dafna.gladman{at}utoronto.ca
Citation
Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?
Publication history
- Accepted June 12, 2010
- First published July 13, 2010.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions